Menopause and fertility issues rarely appear in an absence report. They appear in resignations, quiet sick days and careers that stall at the point you most need them. Enter a few numbers about your workforce to estimate what that costs each year.
How this is calculated
Menopause: 13.4% of working women aged 45 to 60 reported adverse work outcomes from menopause symptoms (Faubion et al., Mayo Clinic Proceedings, 2023). Infertility: about 1 in 6 adults are affected in their lifetime (World Health Organization, 2023). Replacing an employee costs one-half to two times their annual salary (Gallup, 2019); the headline figure uses the low end, and the range shows both ends. Exit rate and days lost are your own assumptions. This is an estimate for planning, not a forecast.
What the research shows in Asia
A 2025 study by NUS Medicine and HeyVenus surveyed 1,741 working women in Singapore, Vietnam, Australia, Japan and Indonesia.
- Nearly half said menopause symptoms significantly disrupted their work.
- Close to half had never sought professional advice for their symptoms.
- 61% said stigma stops them raising symptoms or asking for support at work.
- Close to 90% of women, and most people managers, said a menopause-friendly policy would benefit the organisation. Only about a third of companies have one.
Turn the estimate into a plan
Zora Health designs fertility, menopause and family health benefits for employers across Asia, from a single policy to a full programme with care navigation and clinic access. We will walk you through your numbers and what a programme would change.
Book a complimentary consultation